Relative association of bowel urgency improvement versus remission of stool frequency and rectal bleeding with Patient Global Rating of Severity or Change scores in moderately-to-severely active Ulcerative Colitis: An analysis from the LUCENT-1 and LUCENT-2 Phase 3 trials

被引：0
|
作者：
Travis, S. [1 ]
Wu, J. [2 ]
Keohane, A. [2 ]
Gibble, T. H. [2 ]
Hibi, T. [3 ]
机构：
[1] Univ Oxford, Gastroenterol, Oxford, England
[2] Eli Lilly & Co, Immunol, Indianapolis, IN USA
[3] Kitasato Inst Hosp Kitasato Univ, Ctr Adv IBD Res & Treatment, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P743
引用
收藏
页码：873 / 873
页数：1
相关论文
共 14 条
  • [1] Relative association of bowel urgency clinically meaningful improvement or bowel urgency remission versus stool frequency remission and rectal bleeding remission with improvement in Inflammatory Bowel Disease Questionnaire scores in patients with moderately-to-severely active Ulcerative Colitis: An analysis from LUCENT-1 and LUCENT-2 phase 3 clinical trials
    Sands, B. E.
    Feagan, B.
    Gibble, T. H.
    Keohane, A.
    Eastman, W.
    Traxler, K.
    Schreiber, S.
    Jairath, V.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 523 - 524
  • [2] Relative association of bowel urgency clinically meaningful improvement and bowel urgency remission versus stool frequency remission and rectal bleeding remission with improvement in Work Productivity and Activity Impairment Scores in patients with moderately-to-severely active Ulcerative Colitis: An analysis from LUCENT-1 and LUCENT-2 Phase 3 clinical trials.
    Sands, B. E.
    Feagan, B. G.
    Gibble, T. H.
    Keohane, A.
    Eastman, W. J.
    Traxler, K. A.
    Schreiber, S.
    Jairath, V.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 775 - 776
  • [3] BOWEL URGENCY OUTCOMES ARE ASSOCIATED WITH IMPROVEMENT IN FATIGUE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: A POOLED ANALYSIS OF LUCENT-1 AND LUCENT-2 PHASE 3 TRIALS
    Rubin, David T.
    Hindryckx, Pieter
    Hibi, Toshifumi
    McGinnis, Kim
    Gibble, Theresa H.
    Keohane, Anthony
    Regueiro, Miguel D.
    GASTROENTEROLOGY, 2023, 164 (06) : S213 - S213
  • [4] RELATIVE ASSOCIATION OF BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT OR BOWEL URGENCY REMISSION VS STOOL FREQUENCY REMISSION AND RECTAL BLEEDING REMISSION WITH IMPROVEMENT IN IBDQ SCORES: RESULTS FROM LUCENT-1 AND LUCENT-2
    Sands, Bruce E.
    Feagan, Brian G.
    Gibble, Theresa H.
    Keohane, Anthony
    Eastman, William J.
    Traxler, Kristina A.
    Schreiber, Stefan
    Jairath, Vipul
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2023, 164 (06) : S686 - S687
  • [5] Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies
    Long, Millie D.
    Schreiber, Stefan
    Hibi, Toshifumi
    Gibble, Theresa Hunter
    Fisher, Deborah A.
    Park, Gina
    Moses, Richard E.
    Higgins, Peter D. R.
    Lindsay, James O.
    Lee, Scott D.
    Escobar, Rodrigo
    Jairath, Vipul
    CROHNS & COLITIS 360, 2024, 6 (01)
  • [6] Mirikizumab Demonstrates Sustained Improvement in Fatigue in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
    Regueiro, Miguel
    Gibble, Theresa Hunter
    Bleakman, Alison Potts
    Li, Xingyuan
    Morris, Nathan
    Eastman, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S518 - S519
  • [7] Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
    Sands, Bruce E.
    Feagan, Brian G.
    Gibble, Theresa Hunter
    Traxler, Kristina A.
    Morris, Nathan
    Eastman, William J.
    Schreiber, Stefan
    Jairath, Vipul
    Long, Millie D.
    Armuzzi, Alessandro
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [8] Mirikizumab Significantly Improves Abdominal Pain in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
    Loftus, Edward V.
    Gibble, Theresa Hunter
    Bleakman, Alison Potts
    Li, Xingyuan
    Morris, Nathan
    Hon, Emily
    Jairath, Vipul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S533 - S534
  • [9] IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
    Long, Millie
    Gisbert, Javier
    McGinnis, Kim
    Ferrante, Marc
    Rogler, Gerhard
    Sapin, Christophe
    Hunter, Theresa
    Milata, Joe
    Navabi, Seyedehsan
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S10 - S11
  • [10] Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies
    Kobayashi, Taku
    Matsuoka, Katsuyoshi
    Watanabe, Mamoru
    Hisamatsu, Tadakazu
    Hirai, Fumihito
    Milata, Joe
    Li, Xingyuan
    Morris, Nathan
    Arora, Vipin
    Ishizuka, Tomoko
    Matsuo, Koji
    Satoi, Yoichi
    Milch, Catherine
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2024, 22 (02) : 172 - 185
12